⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 31, 2012Journal of Crohn s and Colitis

Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab

Kum C. Fok Watson Wa-Sang Ng Christopher J.A. Henderson Susan J. Connor

View at Publisher

Ask AI

Bookmark

Share

Abstract

The advance of anti-tumour necrosis factor (TNF) therapy had dramatically changed the treatment algorithm of inflammatory bowel disease (IBD). This had significantly improved the quality of life for patients with Crohn's disease (CD) and ulcerative colitis (UC).(1) However, side-effects of anti-TNF treatment were unavoidable with paradoxical inflammation (for example leucocytoclastic vasculitis and psoriasis) being well-known phenomena of anti-TNF therapy.(2) We report a case of infliximab induced cutaneous sarcoidosis in a patient with ulcerative colitis and review the literature.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Fok et al. (2012) studied this question.

synapsesocial.com/papers/6a63efaeccedfd04c992865c https://doi.org/10.1016/j.crohns.2012.01.008

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 casesOriginal Research · 2009 · 265 citations
2Sarcoidosis During Anti-Tumor Necrosis Factor-α Therapy: No Relapse After RechallengeCase Report · 2009 · 33 citations
3Association of <i>TNF</i> polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-α levels in Asian IndiansCohort Study · 2007 · 79 citations
4Plasma lipopolysaccharide-binding protein (LBP), a proxy for intestinal permeability, relates to clinicopathological and immunological disease activity in inflammatory bowel disease patients at diagnosis and during disease courseJournal of Crohn s and Colitis · Mon,
5Targeting epithelial IFN-I signaling restores barrier integrity in anti-TNF refractory Crohn’s diseaseJournal of Crohn s and Colitis · Tue,

More from Journal of Crohn s and Colitis

Orofacial granulomatosis associated with Crohn’s disease: clinical phenotype and response to biologics and Janus kinase inhibitor therapy in a large multi-center cohortTue,
Distinct intestinal eosinophil subsets in ulcerative colitis and their modulation by advanced inflammatory bowel disease therapiesTue,
Single-cell insights into drug response and resistance in inflammatory bowel disease: cellular hallmarks and precision therapyTue,
Evaluating sonographic response and remission in inflammatory bowel disease: aligning intestinal ultrasound assessment with STRIDE-II timelinesTue,
Isolated perianal fistulizing Crohn’s disease in contemporary clinical practice: a multicenter ECCO-CONFER cohort studyFri,